Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
View up-to-date information on Reata Pharmaceuticals Inc patents, including inventor and filing insights.
Patent Trends
| Publication Identifier | Document Type | Title | Classification-CPC | Publication Date |
|---|---|---|---|---|
| EP4277916A1 | Application | Synthetische ursolsäurederivate und verfahren zur verwendung davon | A61P1/18; A61P11/00; A61P11/06; A61P13/12; A61P17/00; A61P19/02; A61P21/06; A61P25/00; A61P25/28; A61P27/02; A61P29/00; A61P3/00; A61P3/10; A61P31/04; A61P31/16; A61P35/00; A61P37/06; A61P7/06; A61P9/00; A61P9/10; C07J63/008; C07J71/0005 | November 22, 2023 |
| US11814338B2 | Grant | Pyrazolyl and pyrimidinyl tricyclic enones as antioxidant inflammation modulators | C07C255/47; C07D231/54; C07D239/70; C07D401/04; C07D403/04; C07D413/04; C07D417/04; C07D487/04 | November 14, 2023 |
| KR1020230147077A | Application | 합성 우르솔산 유도체 및 이의 사용 방법 | A61P1/18; A61P11/00; A61P11/06; A61P13/12; A61P17/00; A61P19/02; A61P21/06; A61P25/00; A61P25/28; A61P27/02; A61P29/00; A61P3/00; A61P3/10; A61P31/04; A61P31/16; A61P35/00; A61P37/06; A61P7/06; A61P9/00; A61P9/10; C07J63/008; C07J71/0005 | October 20, 2023 |
| PE20231661A1 | Application | Derivados de acido ursolico sinteticos y metodos de uso de los mismos | A61P1/18; A61P11/00; A61P11/06; A61P13/12; A61P17/00; A61P19/02; A61P21/06; A61P25/00; A61P25/28; A61P27/02; A61P29/00; A61P3/00; A61P3/10; A61P31/04; A61P31/16; A61P35/00; A61P37/06; A61P7/06; A61P9/00; A61P9/10; C07J63/008; C07J71/0005 | October 17, 2023 |
| CA2974726C | Grant | Imidazolyl tricyclic enones as antioxidant inflammation modulators | A61K31/4184; A61P29/00; C07C235/02; C07D235/02; C07D235/08; C07D235/10; C07D235/12; C07D401/04; C07D403/04; C07D403/10; C07D403/14 | September 19, 2023 |
Top Inventors by Filings (Count by publication)
| Name | Count |
|---|
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer